TÜV SÜD Danmark ApS receives designation as Notified Body in accordance with MDR 2017/745
TÜV SÜD Danmark ApS today received its designation as Notified Body 2443 under Medical Device Regulation 2017/745 by the…
TÜV SÜD Danmark ApS today received its designation as Notified Body 2443 under Medical Device Regulation 2017/745 by the…
TÜV SÜD is one of the few notified bodies that still has capacities for conformity assessment procedures for medical dev…
First iPSC therapy candidate to be licensed from the strategic R&D collaboration forged between BlueRock, FUJIFILM Cellu…
Fresenius drives forward the vision of Health Equity with signature. The company offers broad access to healthcare and a…
France Biotech, the association of health innovation entrepreneurs, represented by its President Franck Mouthon, and the…
First-in-human trial of AB-1002 designed to establish safety and preliminary efficacy in patients with NYHA Class III He…
The Notified Body TÜV SÜD Product Service GmbH released the first certificate for a non-medical purpose device according…
TÜV SÜD is calling for further advancement of the procedure used for mandatory penetration testing for medical devices a…
Hamburg Commercial Bank (HCOB) is sponsoring the “Rowing against Cancer” regattas of the “Leben mit Krebs” (Living with…
Researchers from the Ebisuya Group at EMBL Barcelona have used an unprecedented stem cell zoo to compare six different m…